StockData
Integra LifeSciences Holdings Corp logo

Integra LifeSciences Holdings Corp (IART) stock

IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.55−0.43 (-3.08%)

Close on Nov 17, 2026Market cap $1.05BP/E 79.7Yield –

Integra LifeSciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Integra LifeSciences's enterprise value was $865.60M on Nov 11, 2026, against $736.99M a year earlier. Over the last 5 years it ranged from $458.51M to $5.24B, with a median of $1.78B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$865.60M+26.7%
2025Dec 31, 2025$683.38M-53.8%
2024Dec 31, 2024$1.48B-55.0%
2023Dec 29, 2023$3.29B-22.0%
2022Dec 30, 2022$4.21B-19.6%
2021Dec 31, 2021$5.24B+1.8%
2020Dec 31, 2020$5.15B+6.9%
2019Dec 31, 2019$4.82B+37.4%
2018Dec 31, 2018$3.51B+5.8%
2017Dec 29, 2017$3.31B-0.2%
2016Dec 30, 2016$3.32B+49.3%
2015Dec 31, 2015$2.22B+52.8%
2014Dec 31, 2014$1.45B+33.6%
2013Dec 31, 2013$1.09B+23.5%
2012Dec 31, 2012$881.95M+22.4%
2011Dec 30, 2011$720.46M-39.9%
2010Dec 31, 2010$1.20B+57.3%
2009Dec 31, 2009$762.47M–

More Integra LifeSciences figures

See a number that looks wrong?